Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer. Cancer. 2020 09 01; 126(17):3972-3981.
View in:
PubMed
subject areas
Adult
Aged
Female
Humans
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
Proto-Oncogene Proteins p21(ras)
Quinolones
Salivary Gland Neoplasms
Treatment Outcome
authors with profiles
Ezra Cohen